Cargando…
Inadequate therapeutic responses to glucocorticoid treatment in bronchial asthma
Bronchial asthma (BA) is a heterogeneous disease. Some patients benefit greatly from glucocorticoid (GC) treatment, whereas others are non-responders. This could be attributable to differences in pathobiology. Thus, predicting the responses to GC treatment in patients with BA is necessary to increas...
Autor principal: | Matsumura, Yasuhiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10280542/ https://www.ncbi.nlm.nih.gov/pubmed/37296513 http://dx.doi.org/10.1177/03000605231175746 |
Ejemplares similares
-
Heterogeneity of Glucocorticoid Resistance in Patients with Bronchial Asthma
por: Matsumura, Yasuhiro
Publicado: (2010) -
The Treatment of Bronchial Asthma
Publicado: (1947) -
On Bronchial Asthma
Publicado: (1890) -
Advances and Challenges of Antibody Therapeutics for Severe Bronchial Asthma
por: Abe, Yuko, et al.
Publicado: (2021) -
On Bronchial Asthma: Its Pathology and Treatment
Publicado: (1890)